Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

ClinicalTrials.gov ID: NCT01151098

Public ClinicalTrials.gov record NCT01151098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center, Titration Study to Establish the Long-term Safety and Tolerability of Buprenorphine Transdermal Delivery System (BTDS) 5 mg, 10 mg, and 20 mg in Patients With Chronic Non-Malignant Pain Syndromes Responsive to Opioid Combination Therapy - a 28-Week Extension Study.

Study identification

NCT ID
NCT01151098
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

  • Buprenorphine transdermal patch Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2001
Primary completion
Jan 31, 2002
Completion
Jan 31, 2002
Last update posted
Sep 9, 2012

2001 – 2002

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Arizona Research Center Inc. Phoenix Arizona 85023
Clinical Research Consultants Inc Trumbull Connecticut 06611
Tampa Bay Medical Research Inc Clearwater Florida 33761
Clinical Research of South Florida Coral Gables Florida 33134
University Clinical Research Deland DeLand Florida 32720
University Clinical Research Inc, Pembroke Pines Florida 33024
Gold Coast Research, LLC Plantation Florida 33324
Gold Coast Research LLC Tamarac Florida 33321
Family Medicine Associates Evansville Indiana 47712
Pain Management & Rehabilitation Terre Haute Indiana 47807
Southeastern Center for Headache and Pain Crestview Heights Kentucky 41017
Westside Family Medical Center PC Kalamazoo Michigan 49009
The Arthritis Clinic Charlotte North Carolina 28211
Cornerstone Research Care High Point North Carolina 27262
ALL-TRIALS Clinical Research LLC Winston-Salem North Carolina 27103
Summit Research Solutions Memphis Tennessee 38119
Radiant Research - Austin Austin Texas 78758
Wasatch Clinical Research Salt Lake City Utah 84107
Clinical Research Management New Berlin Wisconsin 53151

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01151098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01151098 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →